Literature DB >> 4830160

Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials.

R C Urtasun, J Sturmwind, H Rabin, P R Band, J D Chapman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4830160     DOI： 10.1259/0007-1285-47-557-297-c

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  15 in total

1.  Peripheral neuropathy related to misonidazole: incidence and pathology.

Authors:  R C Urtasun; J D Chapman; M L Feldstein; R P Band; H R Rabin; A F Wilson; B Marynowski; E Starreveld; T Shnitka
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 2.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

3.  Treatment of malignant gliomas in adults with BCNU plus metronidazole.

Authors:  D J Stewart; B Benoit; M T Richard; H Hugenholtz; J Dennery; N Russell; E Peterson; Z Grahovac; G Belanger; J A Maroun
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

4.  Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimidazoles.

Authors:  D G Lindmark; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

5.  Mitomycin-C plus metronidazole in advanced carcinoma of the breast.

Authors:  D J Stewart; J A Maroun; B Lefebvre; R Heringer; A F Crook
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Metronidazole neuropathy.

Authors:  A Coxon; C A Pallis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

7.  Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis.

Authors:  M L Britz; R G Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

8.  Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results.

Authors:  J L Foster; I R Flockhart; S Dische; A Gray; I Lenox-Smith; C E Smithen
Journal:  Br J Cancer       Date:  1975-06       Impact factor: 7.640

9.  Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.

Authors:  R Urtasun; M L Feldstein; J Partington; H Tanasichuk; J D Miller; D B Russell; O Agboola; B Mielke
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

10.  Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.

Authors:  P W Sheldon; J L Foster; J F Fowler
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.